Announcement on Plan of Shareholding Reduction by Shareholder
Filed with SSE · · 5 pages · Chinese
CABIO Biotech (Wuhan) Co. Ltd. on 6ix
Earlier from CABIO Biotech (Wuhan)
- Announcement on Adjusting the Upper Limit of Phase II Share Repurchase Price after Implementation of Dividend Distribution for 2024
- Announcement on Reply to the Review Inquiry Letter of Application for Purchasing Assets and Raising Supporting Funds by Issuing Shares and Paying Cash as well as Related Party Transactions
- Announcement on Convening the Q1 2025 Performance Briefing
- Announcement on Resolution of the 2024 Annual General Meeting
- Announcement on Changing Major Asset Restructuring Project and Audit Signatory Accountant for 2025
Later from CABIO Biotech (Wuhan)
- Announcement on Voluntary Disclosure of Earnings Pre-increase for 2025 Interim Results
- Announcement on the Halfway Point of the 2nd Share Repurchase Period Without Any Repurchase Implemented
- Announcement on Resolutions of the 7th Meeting of the 4th Board of Supervisors
- Announcement on Holding the Investors' Briefing on Terminating Major Asset Restructuring
- Announcement on Cancellation of Some Special Accounts for Raised Funds
Follow CABIO Biotech (Wuhan) into a list and get an email when it puts out news.
Follow CABIO Biotech (Wuhan)